FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Clomiphene and toremifene inhibit Ebola virus infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,303
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Self-citationEndosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection
Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., & Cunningham, J. M. (2005) · Science · doi:10.1126/science.1110656 · Cited by 826
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
Côté, M., Misasi, J., Ren, T., Bruchez, A., Lee, K., Filone, C. M., Hensley, L., Li, Q., Ory, D., Chandran, K., et al. (2011) · Nature · doi:10.1038/nature10380 · Cited by 686
Self-citationA Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
Cavrois, M., de Noronha, C., & Greene, W. C. (2002) · Nature Biotechnology · doi:10.1038/nbt745 · Cited by 475 · cited 1×
“EBOV entry and internalization assays The b-lactamase (BlaM) entry assay (42) was adapted for assessing effects of candidate inhibitory compounds on EBOV VLP entry as follows.”
MethodEpitopes Involved in Antibody-Mediated Protection from Ebola Virus
Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L., & Hart, M. K. (2000) · Science · doi:10.1126/science.287.5458.1664 · Cited by 459
Nanbo, A., Imai, M., Watanabe, S., Noda, T., Takahashi, K., Neumann, G., Halfmann, P., & Kawaoka, Y. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001121 · Cited by 437
Saeed, M. F., Kolokoltsov, A. A., Albrecht, T., & Davey, R. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001110 · Cited by 427
Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein
Schornberg, K., Matsuyama, S., Kabsch, K., Delos, S., Bouton, A., & White, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.4174-4178.2006 · Cited by 414
Self-citationEbola virus entry requires the host‐programmed recognition of an intracellular receptor
Miller, E. H., Obernosterer, G., Raaben, M., Herbert, A. S., Deffieu, M. S., Krishnan, A., Ndungo, E., Sandesara, R. G., Carette, J. E., Kuehne, A. I., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.53 · Cited by 335
Pathogenesis of filoviral haemorrhagic fevers
Mahanty, S., & Bray, M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01103-x · Cited by 310
Dengue Virus Ensures Its Fusion in Late Endosomes Using Compartment-Specific Lipids
Zaitseva, E., Yang, S.-T., Melikov, K., Pourmal, S., & Chernomordik, L. V. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001131 · Cited by 287
Cathepsin L and Cathepsin B Mediate Reovirus Disassembly in Murine Fibroblast Cells
Ebert, D. H., Deussing, J., Peters, C., & Dermody, T. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201107200 · Cited by 279
Expression of an Estrogen Receptor by Human Coronary Artery and Umbilical Vein Endothelial Cells
Kim-Schulze, S., McGowan, K. A., Hubchak, S. C., Cid, M. C., Martin, M. B., Kleinman, H. K., Greene, G. L., & Schnaper, H. W. (1996) · Circulation · doi:10.1161/01.cir.94.6.1402 · Cited by 218
Selective estrogen receptor modulators: an update on recent clinical findings
Shelly, W., Draper, M. W., Krishnan, V., Wong, M., & Jaffe, R. B. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31816400d7 · Cited by 193 · cited 3×
“The aim was to characterize the anti-filovirus activity of two ER antagonist compounds: clomiphene and toremifene (5).”
BackgroundTowner, J. S., Paragas, J., Dover, J. E., Gupta, M., Goldsmith, C. S., Huggins, J. W., & Nichol, S. T. (2005) · Virology · doi:10.1016/j.virol.2004.10.048 · Cited by 176
Pharmacokinetics of Selective Estrogen Receptor Modulators
Morello, K. C., Wurz, G. T., & DeGregorio, M. W. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00004 · Cited by 174
Single-dose pharmacokinetics of clomiphene citrate in normal volunteers
Mikkelson, T. J., Kroboth, P. D., Cameron, W. J., Dittert, L. W., Chungi, V., & Manberg, P. J. (1986) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49574-9 · Cited by 170
Yonezawa, A., Cavrois, M., & Greene, W. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.918-926.2005 · Cited by 163
Brecher, M. B., Schornberg, K. L., Delos, S. E., Fusco, M. L., Saphire, E. O., & White, J. M. (2011) · Journal of Virology · doi:10.1128/jvi.05708-11 · Cited by 157
Self-citationA Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C. S., & Huggins, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/514292 · Cited by 153
Shoemaker, C. J., Schornberg, K. L., Delos, S. E., Scully, C., Pajouhesh, H., Olinger, G. G., Johansen, L. M., & White, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056265 · Cited by 147
Self-citationDube, D., Brecher, M. B., Delos, S. E., Rose, S. C., Park, E. W., Schornberg, K. L., Kuhn, J. H., & White, J. M. (2009) · Journal of Virology · doi:10.1128/jvi.01956-08 · Cited by 146
Self-citationEbola virus: new insights into disease aetiopathology and possible therapeutic interventions
Geisbert, T. W., & Hensley, L. E. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404008300 · Cited by 142
Self-citationFilovirus Entry: A Novelty in the Viral Fusion World
Hunt, C. L., Lennemann, N. J., & Maury, W. J. (2012) · Viruses · doi:10.3390/v4020258 · Cited by 117
Rapid detection protocol for filoviruses
Weidmann, M., Mühlberger, E., & Hufert, F. T. (2003) · Journal of Clinical Virology · doi:10.1016/j.jcv.2003.09.004 · Cited by 108
Filoviruses: Interactions with the host cell
Dolnik, O., Kolesnikova, L., & Becker, S. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7406-2 · Cited by 99
Ebola Virus Glycoprotein 1: Identification of Residues Important for Binding and Postbinding Events
Brindley, M. A., Hughes, L. J., Ruiz, A. J., McCray, P. B., Sanchez, A., Sanders, D. A., & Maury, W. J. (2007) · Journal of Virology · doi:10.1128/jvi.02433-06 · Cited by 92
Ebihara, H., Theriault, S., Neumann, G., Alimonti, J. B., Geisbert, J. B., Hensley, L. E., Groseth, A., Jones, S. M., Geisbert, T. W., Kawaoka, Y., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/520590 · Cited by 85
Self-citationA new player in the puzzle of filovirus entry
White, J. M., & Schornberg, K. L. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2764 · Cited by 81
Self-citationEbola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion
Bale, S., Liu, T., Li, S., Wang, Y., Abelson, D. M., Fusco, M. L., Woods, V. L., & Saphire, E. O. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001395 · Cited by 71
Characterization of Fluorescent Sterol Binding to Purified Human NPC1
Liu, R., Lu, P., Chu, J. W. K., & Sharom, F. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m803741200 · Cited by 66
Kunz, S. (2009) · Virology · doi:10.1016/j.virol.2009.02.042 · Cited by 65
Estrogen Receptors α and β Have Similar Activities in Multiple Endothelial Cell Pathways
Evans, M. J., Harris, H. A., Miller, C. P., Karathanasis, S. K., & Adelman, S. J. (2002) · Endocrinology · doi:10.1210/en.2002-220356 · Cited by 55
Gene therapy for severe combined immune deficiency
Qasim, W., Gaspar, H. B., & Thrasher, A. J. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404007884 · Cited by 53
Tóth, B., Saadat, G., Geller, A., Scholz, C., Schulze, S., Friese, K., & Jeschke, U. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0426-7 · Cited by 52
Dube, D., Schornberg, K. L., Shoemaker, C. J., Delos, S. E., Stantchev, T. S., Clouse, K. A., Broder, C. C., & White, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008509107 · Cited by 44
Self-citationThe future of the new selective estrogen receptor modulators
Palacios, S. (2007) · Menopause international · doi:10.1258/175404507780456791 · Cited by 36
Cited by
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03036-14 · Cited by 660
Self-citationOestereich, L., Lüdtke, A., Wurr, S., Rieger, T., Muñoz-Fontela, C., & Günther, S. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.02.014 · Cited by 493
Si, L., Bai, H., Rodas, M., Cao, W., Oh, C. Y., Jiang, A., Moller, R., Hoagland, D., Oishi, K., Horiuchi, S., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00718-9 · Cited by 440
“These drugs were chosen based on the hypothesis that they might have broad-spectrum antiviral activity because they have been shown to inhibit infection by other SARS, influenza, and Ebola viruses in prior publications 35–37 .”
Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
Mauvais-Jarvis, F., Klein, S. L., & Levin, E. R. (2020) · Endocrinology · doi:10.1210/endocr/bqaa127 · Cited by 266
Metadata
- Authors
- Johansen, L. M., Brannan, J. M., Delos, S. E., Shoemaker, C. J., Stossel, A., Lear, C., Hoffstrom, B. G., DeWald, L. E., Schornberg, K. L., Scully, C., Lehár, J., Hensley, L. E., White, J. M., & Olinger, G. G.
- Venue
- Science Translational Medicine
- Published
- 2013-06-19
- Volume
- 5
- Issue
- 190
- Pages
- 190ra79-190ra79
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2150837053
- Cited by
- 332
- References
- 40
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.